Patent US4789545A successfully refreshed from Google Patents.
US4789545A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
Assignee: New York Blood Center
•
Filing: 1986-03-31
•
Granted: 1988-12-06
•
Expires: 2006-03-31
Abstract
Abstract A method of removing lipid soluble process chemicals from biological materials containing the lipid soluble process chemicals comprising bringing the biological materials containing the lipid soluble process chemicals into contact with an effective amount of a naturally occurring oil extracted from a plant or an animal or a synthetic compound of similar chemical structure, agitating the resultant mixture, separating out an upper-phase and a lower-phase by sedimentation and decanting the upper-phase. The method is particularly useful for producing relatively virus free physiologically acceptable plasma.
Inventors
- 👤 Kenneth R. Woods
- 👤 Thomas W. Orme
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 11:33
CPC Classifications
A; A61; A61L; A61L2/00; A61L2/16; A61L2/18; A61K; A61K35/00; A61K35/12; A61K35/14; A61K35/16; A61L2103/00; A61L2103/05
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
134 words
A method of removing lipid soluble process chemicals from biological materials comprising blood plasma and fractions thereof containing said lipid soluble process chemicals, said lipid soluble process chemical being a virus attenuating solvent having a high flash point, a detergent, or a mixture thereof, comprising bringing said biological materials containing said lipid soluble process chemicals into contact with an effective amount of a naturally occurring oil extracted from a plant or an animal or a synthetic compound of similar chemical structure so as to remove 80% or more of said lipid soluble process chemicals, the oil being nonflammable, nonexplosive, compatible with parenterally administered biologics and blood derivatives and pharmaceutically and physiologically tolerable by a human, agitating the resultant mixture, separating out an upper-phase and a lower-phase by sedimentation or centrifugation and decanting the upper-phase.
Claim 2
Independent Claim
134 words
A method of removing lipid soluble process chemicals from biological materials comprising blood plasma and fractions thereof containing said lipid soluble process chemicals, said lipid soluble process chemical being a virus attenuating solvent having a high flash point, a detergent, or a mixture thereof, comprising bringing said biological materials containing said lipid soluble process chemicals into contact with an effective amount of a naturally occurring oil extracted from a plant or an animal or a synthetic compound of similar chemical structure so as to remove 80% or more of said lipid soluble process chemicals, the oil being nonflammable, nonexplosive, compatible with parenterally administered biologics and blood derivatives and pharmaceutically and physiologically tolerable by a human, agitating the resultant mixture, separating out an upper-phase and a lower-phase by sedimentation or centrifugation and decanting the upper-phase.
Claim 3
Dependent Claim
36 words
A method according to claim 1, wherein said oil is selected from the group consisting of soybean oil, safflower oil, ricin oil, cottonseed oil, corn oil, peanut oil, olive oil, whale oil and cod liver oil.
Claim 4
Dependent Claim
17 words
A method according to claim 1, wherein said lipid soluble process chemical is a virus attenuating solvent.
Claim 5
Dependent Claim
11 words
A method according to claim 3, wherein said solvent is N-tributylphosphate.
Claim 6
Dependent Claim
18 words
A method according to claim 3, wherein the virus attenuating solvent is utilized in conjunction with a detergent.
Claim 7
Dependent Claim
16 words
A method according to claim 1, wherein the lipid soluble process chemical is a phorbol ester.
Claim 8
Dependent Claim
14 words
A method according to claim 1, wherein the phorbol ester is a diterpene ester.
Claim 9
Dependent Claim
29 words
A method according to claim 1, wherein the synthetic compound is a synthetic triglyceride and is selected from the group consisting of tristearin, tripalmitin, triolein, trimyristin and combinations thereof.
Claim 10
Dependent Claim
80 words
A method according to claim 1, wherein the biological material is selected from the group consisting of blood plasma, blood serum, Fraction I, Fraction II, Fraction III, Fraction IV-1, Fraction IV-4, Fraction V, Fraction VI, fibronectin, antihemophilic factor, prealbumin, retinol-binding protein, albumin, alpha-globulins, beta-globulins, gamma globulins, antithrombin III, prothrombin, plasminogen, fibrinogen, factor XIII, immunoglubin G, immunoglubin A, immunoglubin M, immunoglubin D and immunoglubin E, plasmin inhibitor, prothrombin, thrombin, antithrombin, factor V, factor VII, factor VIII, factor IX and factor X.
Claim 11
Dependent Claim
28 words
A method according to claim 1, wherein the oil is contained in an amount of 5 to 50 weight %, based on the weight of the biological fluid.
Claim 12
Independent Claim
184 words
A method of removing lymphokine inducing phorbol esters from lymphokine-containing biological materials selected from the group consisting of mammalian blood, platelet concentrates, white cell concentrates, concentrates of granulocytes, concentrates of monocytes, suspension of cells capable of producing interferon, suspension of cells capable of producing tissue necrosis factor, suspension of cells capable of producing other immune modulators and lymphokines, media separated from said concentrates and suspensions, exudate from cancer cells, exudate from normal cells grown in culture, hydridomas, products from gene splicing, plant cell concentrates, plant cell suspensions, extract of animal tissues, extracts of plant tissues and microorganisms, comprising bringing said biological materials containing said phorbol esters into contact with an effective amount of a naturally occurring oil extracted from a plant or an animal or a synthetic compound of similar chemical structure so as to remove 80% or more of the phorbol esters, the oil being nonflammable, non explosive, compatible with parenterally administered biologics and blood derivatives and pharmaceutically and physiologically tolerable by a human, agitating the resultant mixture, separating out an upper-phase and a lower-phase by sedimentation or centrifugation and decanting the upper-phase.
Claim 13
Independent Claim
184 words
A method of removing lymphokine inducing phorbol esters from lymphokine-containing biological materials selected from the group consisting of mammalian blood, platelet concentrates, white cell concentrates, concentrates of granulocytes, concentrates of monocytes, suspension of cells capable of producing interferon, suspension of cells capable of producing tissue necrosis factor, suspension of cells capable of producing other immune modulators and lymphokines, media separated from said concentrates and suspensions, exudate from cancer cells, exudate from normal cells grown in culture, hydridomas, products from gene splicing, plant cell concentrates, plant cell suspensions, extract of animal tissues, extracts of plant tissues and microorganisms, comprising bringing said biological materials containing said phorbol esters into contact with an effective amount of a naturally occurring oil extracted from a plant or an animal or a synthetic compound of similar chemical structure so as to remove 80% or more of the phorbol esters, the oil being nonflammable, non explosive, compatible with parenterally administered biologics and blood derivatives and pharmaceutically and physiologically tolerable by a human, agitating the resultant mixture, separating out an upper-phase and a lower-phase by sedimentation or centrifugation and decanting the upper-phase.
Claim 14
Dependent Claim
36 words
A method according to claim 11, wherein said oil is selected from the group consisting of soybean oil, safflower oil, ricin oil, cottonseed oil, corn oil, peanut oil, olive oil, whale oil and cod liver oil.
Claim 15
Dependent Claim
14 words
A method according to claim 11, wherein the phorbol ester is a diterpene ester.
Claim 16
Dependent Claim
29 words
A method according to claim 11, wherein the synthetic compound is a synthetic triglyceride and is selected from the group consisting of tristearin, tripalmitin, triolein, trimyristin and combinations thereof.
References Cited (Backward Citations)
US3647624A
Cited
US3682835A
Cited
US4522809A
Cited
JPS56127308A
Cited
US4314997A
Cited
EP0050061A2
Cited
US4647536A
Cited
US4481189A
Cited
WO1983004371A1
Cited
US4534972A
Cited
US4540573A
Cited
US4615886A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-12-06 | 1992-06-06 | 1992-12-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-12-06 | 1996-06-06 | 1996-12-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-12-06 | 2000-06-06 | 2000-12-06 | $7700.00 | Window Closed / Lapsed |